Highly efficient in vivo hematopoietic stem cell transduction using an optimized self-complementary adeno-associated virus
Carsten T. Charlesworth(Stanford University), Hiromitsu Nakauchi(Japan Science and Technology Agency), Sicong Wang(Stanford University), Agnieszka Czechowicz(Stanford University), M. Kyle Cromer(University of California, San Francisco), Amanda M. Dudek(Stanford University), Adam C. Wilkinson(Wellcome/MRC Cambridge Stem Cell Institute), Carla Dib(Stanford University), Shota Homma(Stanford University), Kyomi J. Igarashi(Harvard University), Fabian P. Suchy(Stanford University), Alvaro Amorin(Stanford University), Sriram Vaidyanathan(Nationwide Children's Hospital), Anais K. Amaya(Stanford University), Yusuke Nakauchi(Stanford University), Masashi Miyauchi(California Institute for Regenerative Medicine), Tze-Kai Tan(Stanford University)
Cited by 3
Related Papers
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
|Cancer Cell|2018|254
Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers
|Hepatology|2012|195
Rapid Chromatin Switch in the Direct Reprogramming of Fibroblasts to Neurons
|Cell Reports|2017|146
Treatment of a genetic brain disease by CNS-wide microglia replacement
|Science Translational Medicine|2022|126
Sall4 Regulates Cell Fate Decision in Fetal Hepatic Stem/Progenitor Cells
|Gastroenterology|2008|106